leisure time -WSS

leisure time

author：entertainment 2025-10-02 09:47:29 - browse：7

Human embryonic stem cells Annie Cavanagh/Wellcome Images

The Food and Drug Administration on Thursday unveiled a series of guidelines that aim to encourage the development of promising and legitimate stem cell therapies while distinguishing them from the largely untested stem cell treatments hawked by unregulated clinics around the country.

The FDA’s guidelines have been expected and eagerly awaited by the stem cell community given the rapid proliferation of untested — and potentially unsafe — therapies around the country. Clinics promoting these therapies claim to be able to treat ailments from autism to neurodegenerative disorders to erectile dysfunction.

The guidelines also spell out how the agency will implement the regenerative medicine provisions in a behemoth law enacted last year called the 21st Century Cures Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Long Covid needs a new name — and a new frame

focus

WSS

Australia’s approach to dialysis celebrates life

Appeals court upholds limits to abortion pill

How medical schools plan to diversify without affirmative action

AstraZeneca bets AAV gene therapy will still deliver the goods

Radiation, mainstay of cancer treatment, begins a fade

How to make AI work for medicine

explore

leisure time

hotspot

Affirmative action in medical school literally saved lives

How Long Island became the ‘eugenics capital of the world’

Novavax promises a turnaround & Lilly roils the obesity market

Food makers to regulators: Ultra

Walensky prepares to leave CDC — and Congress — behind

FDA panel gives mixed vote on blood pressure devices

Medical leaders decry Supreme Court decision on affirmative action

Long Covid needs a new name — and a new frame

Medical records are filled with copy

How to make AI work for medicine

knowledge

As pharma fights Medicare drug negotiation, hospitals, docs silent

FDA proposes changes to key medical devices approval pathway

What AAP's gender

Neuroscience startup Neumora files for IPO

New Covid vaccine is recommended for everyone 6 months or older

Regeneron agrees to White House price limits on anti

hotspot

focus

focus

explore